Facebook Linkedin Twitter
Inside Precision Medicine NIH-Developed Blood Test Improves Liver Cancer Screening

Liver diseases

A recently-discovered genomic signature for predicting acute rejection in liver transplant recipients will be detailed tomorrow at the American Transplant Congress in Chicago. (Source: © Sebastian Kaulitzki/Fotolia)
Molecular Dx

NIH-Developed Blood Test Improves Liver Cancer Screening

0
ProSciento, Nordic Bioscience Partner to Develop Translational Biomarkers for NASH
News & Features

ProSciento, Nordic Bioscience Partner to Develop Translational Biomarkers for NASH

0
Unhealthy Liver Anatomy
Molecular Dx

Gilead Launches Sequencing Spree After Phase III NASH Flop

0
Illustration of a damaged ribonucleic acid or dna strand
Molecular Dx

CRISPR Enhancement Cures Genetic Disease in Mice

0
Liver Cirrhosis, illustration
News & Features

Oral Microbiome Therapy May Improve Cirrhosis Symptoms

0
Genedrive Wins Grant to Develop Test for Antibiotic-Related Hearing Loss in Newborns
Molecular Dx

Genedrive Wins Grant to Develop Test for Antibiotic-Related Hearing Loss in Newborns

0
Hepatitis B viruses and DNA, illustration
Molecular Dx

Droplet Digital PCR Shows High Sensitivity for Hepatitis B Detection

0
Disruptive Research
Molecular Dx

Disruptive Research

Alex Philippidis
0
Male liver anatomy
News & Features

OWL Metabolomics Inks Diagnostics Deal with NuSirt Biopharma

0
Controls for Molecular Diagnostics Testing
News & Features

Controls for Molecular Diagnostics Testing

0
1...456Page 6 of 6

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine